These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18644861)

  • 41. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.
    Reinhardt HC; Yaffe MB
    Curr Opin Cell Biol; 2009 Apr; 21(2):245-55. PubMed ID: 19230643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple facets of the DNA damage response contribute to the radioresistance of mouse mesenchymal stromal cell lines.
    Sugrue T; Brown JA; Lowndes NF; Ceredig R
    Stem Cells; 2013 Jan; 31(1):137-45. PubMed ID: 22961695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
    Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
    Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. USP39 regulates DNA damage response and chemo-radiation resistance by deubiquitinating and stabilizing CHK2.
    Wu J; Chen Y; Geng G; Li L; Yin P; Nowsheen S; Li Y; Wu C; Liu J; Zhao F; Kim W; Zhou Q; Huang J; Guo G; Zhang C; Tu X; Gao X; Lou Z; Luo K; Qiao H; Yuan J
    Cancer Lett; 2019 May; 449():114-124. PubMed ID: 30771428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.
    Matsuoka S; Rotman G; Ogawa A; Shiloh Y; Tamai K; Elledge SJ
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10389-94. PubMed ID: 10973490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation.
    Ahn JY; Schwarz JK; Piwnica-Worms H; Canman CE
    Cancer Res; 2000 Nov; 60(21):5934-6. PubMed ID: 11085506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.
    Krause DR; Jonnalagadda JC; Gatei MH; Sillje HH; Zhou BB; Nigg EA; Khanna K
    Oncogene; 2003 Sep; 22(38):5927-37. PubMed ID: 12955071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dun1, a Chk2-related kinase, is the central regulator of securin-separase dynamics during DNA damage signaling.
    Yam CQX; Chia DB; Shi I; Lim HH; Surana U
    Nucleic Acids Res; 2020 Jun; 48(11):6092-6107. PubMed ID: 32402080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidative stress induces cell cycle-dependent Mre11 recruitment, ATM and Chk2 activation and histone H2AX phosphorylation.
    Zhao H; Traganos F; Albino AP; Darzynkiewicz Z
    Cell Cycle; 2008 May; 7(10):1490-5. PubMed ID: 18418078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ATM-dependent phosphorylation of ATF2 is required for the DNA damage response.
    Bhoumik A; Takahashi S; Breitweiser W; Shiloh Y; Jones N; Ronai Z
    Mol Cell; 2005 May; 18(5):577-87. PubMed ID: 15916964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
    Pabla N; Huang S; Mi QS; Daniel R; Dong Z
    J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TIS21(/BTG2/PC3) accelerates the repair of DNA double strand breaks by enhancing Mre11 methylation and blocking damage signal transfer to the Chk2(T68)-p53(S20) pathway.
    Choi KS; Kim JY; Lim SK; Choi YW; Kim YH; Kang SY; Park TJ; Lim IK
    DNA Repair (Amst); 2012 Dec; 11(12):965-75. PubMed ID: 23089312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of CHK2 by DNA-dependent protein kinase.
    Li J; Stern DF
    J Biol Chem; 2005 Mar; 280(12):12041-50. PubMed ID: 15668230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex.
    Lee JH; Paull TT
    Science; 2005 Apr; 308(5721):551-4. PubMed ID: 15790808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Point mutation at the Nbs1 Threonine 278 site does not affect mouse development, but compromises the Chk2 and Smc1 phosphorylation after DNA damage.
    Li T; Wang ZQ
    Mech Ageing Dev; 2011 Aug; 132(8-9):382-8. PubMed ID: 21664921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NFBD1, like 53BP1, is an early and redundant transducer mediating Chk2 phosphorylation in response to DNA damage.
    Peng A; Chen PL
    J Biol Chem; 2003 Mar; 278(11):8873-6. PubMed ID: 12551934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains.
    Ng CP; Lee HC; Ho CW; Arooz T; Siu WY; Lau A; Poon RY
    J Biol Chem; 2004 Mar; 279(10):8808-19. PubMed ID: 14681223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner.
    Gibson SL; Bindra RS; Glazer PM
    Cancer Res; 2005 Dec; 65(23):10734-41. PubMed ID: 16322218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J; Tho LM; Xu N; Gillespie DA
    Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.